Related Experiment Videos

HIV-1 protease as a potential target for anti-AIDS therapy

T D Meek¹, G B Dreyer

¹Department of Medicinal Chemistry, Smith Kline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406.

Annals of the New York Academy of Sciences

|January 1, 1990

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Steady-state kinetic characterization of substrates and metal-ion specificities of the full-length and N-terminally truncated recombinant human methionine aminopeptidases (type 2).

Biochemistry·2001

ASP1 (BACE2) cleaves the amyloid precursor protein at the beta-secretase site.

Molecular and cellular neurosciences·2000

Mechanism of inhibition of cathepsin K by potent, selective 1, 5-diacylcarbohydrazides: a new class of mechanism-based inhibitors of thiol proteases.

Biochemistry·2000

Identification of a novel aspartic protease (Asp 2) as beta-secretase.

Molecular and cellular neurosciences·1999

Inhibitors of endothelin.

Medicinal research reviews·1997

Potent inhibition of HIV type 1 infection of mononuclear phagocytes by synthetic peptide analogs of HIV type 1 protease substrates.

AIDS research and human retroviruses·1996

See all related articles